Unity Biotechnology Inc’s recently made public that its Chief Executive Officer Ghosh Anirvan unloaded Company’s shares for reported $557.0 on Nov 04 ’24. In the deal valued at $1.29 per share,432 shares were sold. As a result of this transaction, Ghosh Anirvan now holds 75,893 shares worth roughly $0.13 million.
Then, Sullivan Lynne Marie sold 136 shares, generating $175 in total proceeds. Upon selling the shares at $1.29, the CFO & Head of Corp. Dev. now owns 55,925 shares.
Before that, Nguyen Alexander Hieu sold 149 shares. Unity Biotechnology Inc shares valued at $192 were divested by the Chief Legal Officer at a price of $1.29 per share. As a result of the transaction, Nguyen Alexander Hieu now holds 24,723 shares, worth roughly $42770.79.
Rodman & Renshaw initiated its Unity Biotechnology Inc [UBX] rating to a Buy in a research note published on August 22, 2024; the price target was $8. A number of analysts have revised their coverage, including Wedbush’s analysts, who increased its forecast for the stock in mid November from “a Neutral” to “an Outperform”. ROTH Capital also remained covering UBX and has increased its forecast on January 04, 2022 with a “Buy” recommendation from previously “Neutral” rating. Mizuho revised its rating on November 10, 2021. It rated UBX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of UBX
On Friday, Unity Biotechnology Inc [NASDAQ:UBX] saw its stock jump 2.37% to $1.73. Over the last five days, the stock has lost -3.35%. Unity Biotechnology Inc shares have risen nearly 77.18% since the year began. Nevertheless, the stocks have fallen -1.70% over the past one year. While a 52-week high of $2.02 was reached on 01/07/25, a 52-week low of $0.94 was recorded on 01/02/25. SMA at 50 days reached $1.2400, while 200 days put it at $1.4177.
Levels Of Support And Resistance For UBX Stock
The 24-hour chart illustrates a support level at 1.6767, which if violated will result in even more drops to 1.6233. On the upside, there is a resistance level at 1.7667. A further resistance level may holdings at 1.8033. The Relative Strength Index (RSI) on the 14-day chart is 63.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.2315, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 24.03%. Stochastics %K at 73.41% indicates the stock is a holding.
How much short interest is there in Unity Biotechnology Inc?
A steep rise in short interest was recorded in Unity Biotechnology Inc stocks on 2024-12-31, dropping by 14355.0 shares to a total of 0.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 0.26 million shares. There was a decline of -5.88%, which implies that there is a negative sentiment for the stock.
